Inflammatory and Infectious Diseases Symposium

Related

• 

  Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

  Geoffrey G. Emerson, MD, PhD, FASRS

  Updates from the Field

  2021

• 

  Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength

  Tarek S. Hassan, MD, FASRS

  Updates from the Field

  2019

• 

  Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials

  Carl J Danzig, MD

  Annual Meeting Talks

  2024